1. Xie, Ruihui, Cheng, Liang, Huang, Ming, Chen, Xu, Lin, Tianxin. . NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer. In Cancer research, 83, 1666-1683. doi:10.1158/0008-5472.CAN-22-2233. https://pubmed.ncbi.nlm.nih.gov/36939377/
2. Davis, T A, Loos, B, Engelbrecht, A-M. 2014. AHNAK: the giant jack of all trades. In Cellular signalling, 26, 2683-93. doi:10.1016/j.cellsig.2014.08.017. https://pubmed.ncbi.nlm.nih.gov/25172424/
3. Ghodke, Indrajeet, Remisova, Michaela, Furst, Audrey, Altmeyer, Matthias, Soutoglou, Evi. 2021. AHNAK controls 53BP1-mediated p53 response by restraining 53BP1 oligomerization and phase separation. In Molecular cell, 81, 2596-2610.e7. doi:10.1016/j.molcel.2021.04.010. https://pubmed.ncbi.nlm.nih.gov/33961796/
4. Park, Jun Won, Kim, Il Yong, Choi, Ji Won, Bae, Yun Soo, Seong, Je Kyung. 2018. AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development. In Molecular cancer research : MCR, 16, 1287-1298. doi:10.1158/1541-7786.MCR-17-0726. https://pubmed.ncbi.nlm.nih.gov/29724814/
5. Rudman-Melnick, Valeria, Adam, Mike, Potter, Andrew, Devarajan, Prasad, Potter, S Steven. 2020. Single-Cell Profiling of AKI in a Murine Model Reveals Novel Transcriptional Signatures, Profibrotic Phenotype, and Epithelial-to-Stromal Crosstalk. In Journal of the American Society of Nephrology : JASN, 31, 2793-2814. doi:10.1681/ASN.2020010052. https://pubmed.ncbi.nlm.nih.gov/33115917/
6. Cai, Yanlin, Hu, Yi, Yu, Furong, Sheng, Shunliang, Zhu, Jiayu. 2021. AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway. In Aging, 13, 23579-23587. doi:10.18632/aging.203473. https://pubmed.ncbi.nlm.nih.gov/34689136/
7. Haas, Kelsey M, McGregor, Michael J, Bouhaddou, Mehdi, García-Sastre, Adolfo, Krogan, Nevan J. 2023. Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets. In Nature communications, 14, 6030. doi:10.1038/s41467-023-41442-z. https://pubmed.ncbi.nlm.nih.gov/37758692/
智鼠故事 
